1:25 PM
 | 
Mar 12, 2018
 |  BC Extra  |  Company News

Gilead names new CSO, CMO as Bischofberger departs

Gilead Sciences Inc. (NASDAQ:GILD) said Norbert Bischofberger will step down as EVP of R&D and CSO at the end of April. EVP of Clinical Research John McHutchison will become...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >